The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,369,985 in first-year total cost, median $744,361.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-M (O1)]2
- Special Emphasis Panel[ZDK1 GRB-M (M1)]1
Most frequent institutions
- BOSTON MEDICAL CENTER1
- EMORY UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience1R01DK138309-01 | WEISSBERG-BENCHELL, JILLWOLPERT, HOWARD A | BOSTON MEDICAL CENTER, MA | $899,996 | ZDK1 |
| 2024 | Automated Insulin Delivery for INpatients With DysGlycemia (AIDING)1R01DK138366-01 | PASQUEL, FRANCISCO J | EMORY UNIVERSITY, GA | $744,361 | ZDK1 |
| 2024 | Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy1R01DK140780-01 | POWE, CAMILLE ELISEPUTMAN, MELISSA SUSAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $725,628 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.